Change
Tools:
Print this page Compare to last year's report

Consolidated statement of income


2nd quarter

 

 

 

January - June

2012

 

2013

 

in € millions

 

2012

 

2013

 

 

 

 

 

 

 

 

 

Continuing operations

4,044

 

3,865

 

Revenue

 

7,751

 

7,330

(2,470)

 

(2,332)

 

Cost of sales

 

(4,786)

 

(4,457)

1,574

 

1,533

 

Gross profit

 

2,965

 

2,873

(801)

 

(778)

 

Selling expenses

 

(1,544)

 

(1,493)

(292)

 

(336)

 

General and administrative expenses

 

(604)

 

(654)

(96)

 

(94)

 

Research and development expenses

 

(187)

 

(184)

3

 

(3)

 

Other operating income/(expenses)

 

(6)

 

(3)

388

 

322

 

Operating income

 

624

 

539

(67)

 

(33)

 

Net financing expenses

 

(117)

 

(96)

5

 

6

 

Results from associates and joint ventures

 

9

 

9

326

 

295

 

Profit before tax

 

516

 

452

(89)

 

38

 

Income tax

 

(155)

 

(7)

237

 

333

 

Profit for the period from continuing operations

 

361

 

445

 

 

 

 

 

 

 

 

 

Discontinued operations

4

 

121

 

Profit for the period from discontinued operations

 

(22)

 

114

241

 

454

 

Profit for the period

 

339

 

559

 

 

 

 

 

 

 

 

 

Attributable to

219

 

429

 

Shareholders of the company

 

303

 

518

22

 

25

 

Non-controlling interests

 

36

 

41

241

 

454

 

Profit for the period

 

339

 

559

Copyright © 2013 Akzo Nobel N.V.